The astrocytomas are currently graded from 2 to 4 according to World Health Organization 2021 central nervous system tumor classification. Increasing grade defines increasing malignancy. This study aims to explore the potential of radiomics features extracted from multiparametric pre-operative MRI to predict the grade of astrocytomas. For differentiation of grade 2 from grades 3&4, the FLAIR radiomics were predominantly determined by the feature selection procedure. The highest accuracy for differentiating grade 2 from grades 3&4 was 88.04±0.03% (92.37±0.04% precision and 86.76±0.04% recall).
No takes yet. Share an insight, caveat, or question.
Sümer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: